Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Novartis AG (OTC: NVSEF).

Full DD Report for NVSEF

You must become a subscriber to view this report.


Recent News from (OTC: NVSEF)

Allergan: Court Affirms Patent Loss On Eye Drug To Novartis
Source: Getty Images Last week Allergan ( AGN ) lost an appeal in its attempt to protect its Combigan eye drug from generic competition posed by Novartis AG's ( NVS ), ( NVSEF ) Sandoz division: Allergan Inc said on Friday that it had lost its appeal in a patent battle with Novartis ...
Source: SeekingAlpha
Date: December, 28 2017 02:01
Tracking Tweedy Browne Portfolio - Q3 2017 Update
This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne’s 13F portfolio on a quarterly basis. It is based on Tweedy Browne’s regulatory 13F Form filed on 11/14/2017. Please visit our Tracking Tweedy Browne Portfolio series to ge...
Source: SeekingAlpha
Date: November, 20 2017 02:23
Novartis (NVS) Investor Presentation - Slideshow
The following slide deck was published by Novartis AG in conjunction with this Read more ...
Source: SeekingAlpha
Date: September, 18 2017 13:50
Tracking Tweedy Browne Portfolio - Q2 2017 Update
This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne’s (TBGVX) (TWEBX) (TBHDX) (TBCUX) 13F portfolio on a quarterly basis. It is based on Tweedy Browne’s regulatory 13F Form filed on 08/11/2017. Please visit our Tracking Tweed...
Source: SeekingAlpha
Date: August, 13 2017 11:47
Sumitomo Chemical: Riding On The Exciting Self-Driving Automobile Development And The Revival Of Japan Inc.
Investment Thesis Sumitomo Chemical (SOMMF) (SOMMY) is on track to achieve record profitability in 2017. Based on the management guidance, 2018 would be even better. Despite the revenue staying below the peak established in 2014, the feat is made possible largely because of the sustained s...
Source: SeekingAlpha
Date: June, 30 2017 07:44
Novartis Is On The Hunt
Novartis (NVS) (NVSEF) is one of the biggest pharma companies in the world: NVS Market Cap data by YCharts Johnson & Johnson clearly is the biggest one, although JNJ also is active in other industries such as consumer goods and medical devices, but apart from that Novartis clearly ...
Source: SeekingAlpha
Date: June, 01 2017 10:45
Tracking Tweedy Browne Portfolio - Q4 2016 Update
This article is part of a series that provides an ongoing analysis of the changes made to Tweedy Browne's US stock portfolio on a quarterly basis. It is based on Tweedy Browne's regulatory 13F Form filed on 02/07/2017. Please visit our Tracking Tweedy Browne Portfolio series to get an idea...
Source: SeekingAlpha
Date: February, 08 2017 09:21
Novartis Isn't Trading At An Attractive Valuation
I've recently discussed the key reasons I don't think Novartis (NYSE: NVS ) is poised to outperform in 2017, so in this article I will focus on a quantitative valuation of the company to show why I think NVS is currently trading at a fair valuation. Base Case DCF analysis, with inputs be...
Source: SeekingAlpha
Date: January, 31 2017 08:38
Novartis: No Rush To Jump In After The FY 2016 Results
This morning, Novartis (NYSE: NVS ) ( OTCPK:NVSEF ) reported in-line Q4/2016 results but a highly disappointing guidance for 2017. The stock is up 2% but mainly on short covering given the bearish sentiment into the results and the underperformance in the previous weeks. The question n...
Source: SeekingAlpha
Date: January, 25 2017 08:54
'Fifty Shades Of Pair Trades' Series - End Of Week 1, Featuring: Long Teva - Short Mylan
Background In order to assist those of who haven't read any of my previous articles in better understanding the concepts ad logic behind this new series, I'll sum up who I am and what is my current stance regarding the markets in a nutshell: I am a fund manager who is very minded of ri...
Source: SeekingAlpha
Date: January, 09 2017 08:23

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-21N/A82.20N/AN/A65
2018-08-2082.2082.2082.2082.20130
2018-08-1482.119582.17582.17582.119519,639
2018-08-1382.4282.4282.4282.42400
2018-08-1081.60580.9081.60580.902,300

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1727953751.9553Short
2018-08-091111100.0000Short
2018-08-0860200,4760.0299Cover
2018-08-0760362396.7897Short
2018-07-27250202,9000.1232Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NVSEF.


About Novartis AG (OTC: NVSEF)

Logo for Novartis AG (OTC: NVSEF)

Not available

 

Contact Information

 

 

Current Management

  • Daniel Vasella / President
  • Raymond Breu / CFO

Current Share Structure

  • Market Cap: $214,194,769,773 - 03/09/2018
  • Issue and Outstanding: 2,637,623,000 - 06/30/2010

 


Recent Filings from (OTC: NVSEF)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 16 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 03 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 01 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 19 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 19 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 17 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 09 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 27 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: March, 12 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: February, 09 2018

 

 


Daily Technical Chart for (OTC: NVSEF)

Daily Technical Chart for (OTC: NVSEF)


Stay tuned for daily updates and more on (OTC: NVSEF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: NVSEF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NVSEF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of NVSEF and does not buy, sell, or trade any shares of NVSEF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/